- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
Patent holdings for IPC class A61K 31/706
Total number of patents in this class: 1787
10-year publication summary
|
122
|
136
|
116
|
145
|
158
|
289
|
256
|
221
|
155
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1951 |
65 |
| Nuvamid SA | 59 |
44 |
| Société des Produits Nestlé S.A. | 9245 |
32 |
| Celgene Corporation | 1468 |
32 |
| Elysium Health, Inc. | 74 |
23 |
| Metro International Biotech, LLC | 39 |
23 |
| The Johns Hopkins University | 5533 |
22 |
| ChromaDex Inc. | 92 |
22 |
| Novartis AG | 11254 |
20 |
| Washington University | 1542 |
19 |
| The Regents of the University of California | 19517 |
18 |
| Cornell University | 3202 |
18 |
| Otsuka Pharmaceutical Co., Ltd. | 1535 |
17 |
| Centre National de La Recherche Scientifique | 10102 |
15 |
| Ohara Pharmaceutical Co., Ltd. | 36 |
14 |
| Emory University | 1588 |
13 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
13 |
| Deciphera Pharmaceuticals, LLC | 201 |
12 |
| Merck Sharp & Dohme LLC | 3751 |
12 |
| Genentech, Inc. | 3869 |
11 |
| Other owners | 1342 |